In a market saturated with pharmaceutical giants and digital health apps, Novabloc is taking a radically different approach: it's building hardware. Their wearable neurostimulation device, NOVABLOC™, aims to replace post-opioids not with more drugs, but with targeted electrical pulses. It’s a bold, hardware-first play in the lucrative—and dangerous—world of pain management.

"They aren't fighting the opioid crisis with awareness campaigns; they're fighting it with engineering."

The technology stack reveals a modern, lightweight approach. Using Tailwind CSS and Squarespace for their web presence keeps the site fast and maintainable, allowing the small team to focus entirely on the hardware and software of the wearable itself. It’s a pragmatic choice: don't over-engineer the marketing site when you're building a medical device.

• Targeted neurostimulation avoids systemic side effects of opioids.
• Wearable form factor allows for mobility during recovery.
• Non-invasive design reduces infection risks compared to implanted stimulators.
• Focuses on the post-operative window—a high-cost, high-risk period for hospitals.